The deal was announced by Amedisys CEO Chris Gerard during the company’s third-quarter earnings call on Oct. 27.
Mr. Gerard said during the call that the company has similar value-based contracts in the works with other payers.
“The remaining plans that have been unwilling to engage on models like this should take note,” Mr. Gerard said. “In a world where clinical capacity is at a premium, we will not work with payers who fail to see the value that we deliver and the quality outcomes we provide for their members.”
The deal encompasses 22 states, Mr. Gerard said, including 15 states where Amedisys had historically not admitted Aetna patients.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
